By Z. Jack. Chaminade University of Honolulu, Hawaii.
He may also confer with any witnesses for the defence 500 mg naprosyn amex rheumatoid arthritis guy, including prisoners of war 500mg naprosyn fast delivery arthritis pain medication meloxicam. He shall have the benefit of these facilities until the term of appeal or petition has expired. Particulars of the charge or charges on which the prisoner of war is to be arraigned, as well as the documents which are generally communicated to the accused by virtue of the laws in force in the armed forces of the Detaining Power, shall be communicated to the accused prisoner of war in a language which he understands, and in good time before the opening of the trial. The same communication in the same circumstances shall be made to the advocate or counsel conducting the defence on behalf of the prisoner of war. The representatives of the Protecting Power shall be entitled to attend the trial of the case, unless, exceptionally, this is held in camera in the interest of State security. He shall be fully informed of his right to appeal or petition and of the time limit within which he may do so. This communication shall likewise be sent to the prisoners’ representative concerned. The Detaining Power shall also immediately communicate to the Protecting Power the decision of the prisoner of war to use or to waive his right of appeal. Furthermore, if a prisoner of war is finally convicted or if a sentence pronounced on a prisoner of war in the first instance is a death sentence, the Detaining Power shall as soon as possible address to the Protecting Power a detailed communication containing: 1) the precise wording of the finding and sentence; 2) a summarized report of any preliminary investigation and of the trial, emphasizing in particular the elements of the prosecution and the defence; 3) notification, where applicable, of the establishment where the sentence will be served. The communications provided for in the foregoing sub- paragraphs shall be sent to the Protecting Power at the address previously made known to the Detaining Power. These conditions shall in all cases conform to the requirements of health and humanity. A woman prisoner of war on whom such a sentence has been pronounced shall be confined in separate quarters and shall be under the supervision of women. In any case, prisoners of war sentenced to a penalty depriving them of their liberty shall retain the benefit of the provisions of Articles 78 and 126 of the present Convention. Furthermore, they shall be entitled to receive and despatch correspondence, to receive at least one relief parcel monthly, to take regular exercise in the open air,to have the medical care required by their state of health,and the spiritual assistance they may desire. Penalties to which they may be subjected shall be in accordance with the provisions of Article 87, third paragraph. Throughout the duration of hostilities, Parties to the conflict shall endeavour, with the co-operation of the neutral Powers concerned, to make arrangements for the accommodation in neutral countries of the sick and wounded prisoners of war referred to in the second paragraph of the following Article. They may, in addition, conclude agreements with a view to the direct repatriation or internment in a neutral country of able- bodied prisoners of war who have undergone a long period of captivity. No sick or injured prisoner of war who is eligible for repatriation under the first paragraph of this Article, may be repatriated against his will during hostilities. The conditions which prisoners of war accommodated in a neutral country must fulfil in order to permit their repatriation shall be fixed, as shall likewise their status, by agreement between the Powers concerned. In general, prisoners of war who have been accommodated in a neutral country, and who belong to the following categories, should be repatriated: 1) those whose state of health has deteriorated so as to fulfil the conditions laid down for direct repatriation; 2) those whose mental or physical powers remain, even after treatment, considerably impaired. If no special agreements are concluded between the Parties to the conflict concerned, to determine the cases of disablement or sickness entailing direct repatriation or accommodation in a neutral country, such cases shall be settled in accordance with the principles laid down in the Model Agreement concerning direct repatriation and accommodation in neutral countries of wounded and sick prisoners of war and in the Regulations concerning Mixed Medical Commissions annexed to the present Convention. The appointment, duties and functioning of these Commissions shall be in conformity with the provisions of the Regulations annexed to the present Convention. Prisoners of war who do not belong to one of the three foregoing categories may nevertheless present themselves for examination by Mixed Medical Commissions, but shall be examined only after those belonging to the said categories. The physician or surgeon of the same nationality as the prisoners who present themselves for examination by the Mixed Medical Commission, likewise the prisoners’ representative of the said prisoners, shall have permission to be present at the examination. Prisoners of war detained in connection with a judicial prosecution or conviction and who are designated for repatriation or accommodation in a neutral country, may benefit by such measures before the end of the proceedings or the completion of the punishment, if the Detaining Power consents. Parties to the conflict shall communicate to each other the names of those who will be detained until the end of the proceedings or the completion of the punishment. In the absence of stipulations to the above effect in any agreement concluded between the Parties to the conflict with a view to the cessation of hostilities, or failing any such agreement, each of the Detaining Powers shall itself establish and execute without delay a plan of repatriation in conformity with the principle laid down in the foregoing paragraph. In either case, the measures adopted shall be brought to the knowledge of the prisoners of war.
Heart failure and mor- tomatic myocardial ischemia in patients with 890–896 tality outcomes in patients with type 2 diabetes type 2 diabetes in the Detection of Ischemia in 108 500 mg naprosyn mastercard arthritis knee webmd. Liraglutide and cardiovascular prospective evaluation of the combined use of converting enzyme inhibitors: a randomised con- outcomes in type 2 diabetes generic naprosyn 250mg arthritis hip pain. Lancet 2008;372:1174–1183 2016;375:311–322 S88 Diabetes Care Volume 40, Supplement 1, January 2017 American Diabetes Association 10. B Treatment c Optimize glucose control to reduce the risk or slow the progression of diabetic kidney disease. A c Optimize blood pressure control to reduce the risk or slow the progression of diabetic kidney disease. A c For people with nondialysis-dependent diabetic kidney disease, dietary pro- tein intake should be approximately 0. For patients on dialysis, higher levels of dietary protein intake should be considered. E c Patients should be referred for evaluation for renal replacement treatment if 2 they have an estimated glomerular ﬁltration rate ,30 mL/min/1. A c Promptly refer to a physician experienced in the care of kidney disease for Suggested citation: American Diabetes Associa- uncertainty about the etiology of kidney disease, difﬁcult management issues, tion. It has not been deter- propriately, and determine whether ne- urine creatinine (Cr) is less expensive but mined whether application of the more phrology referral is needed (Table 10. Early vaccination S90 Microvascular Complications and Foot Care Diabetes Care Volume 40, Supplement 1, January 2017 Table 10. Blood pressure control reduces risk of of achieving near-normoglycemia has The presence of diabetic kidney dis- cardiovascular events (30). In the Action to Control Cardio- therapy reduces the risk of albuminuria (11,12) and type 2 diabetes (1,13–17). B ,70 mmHg and especially ,60 mmHg in albuminuria in short-term studies of dia- c Patients with type 2 diabetes older populations. As a result, clinical betic kidney disease, and may have addi- should have an initial dilated and judgment should be used when attempt- tional cardiovascular beneﬁts (44–46). B encounters patients with diabetes and sure but may not be superior to alterna- c Eye examinations should occur be- kidney disease. However, development of albuminuria but in- trimester and for 1 year postpartum other specialists and providers should creased the rate of cardiovascular events as indicated by the degree of reti- also educate their patients about the pro- (41). A edema may be asymptomatic provide diabetic retinopathy at the time of di- c Intravitreal injections of anti–vascular strong support for screening to detect agnosis should have an initial dilated endothelial growth factor are indi- diabetic retinopathy. If diabetic reti- progression of diabetic retinopathy c The presence of retinopathy is nopathy is present, prompt referral to an (64,65). Women with preexisting type 1 not a contraindication to aspirin ophthalmologist is recommended. Subse- or type 2 diabetes who are planning preg- therapy for cardioprotection, as quent examinations for patients with nancy or who have become pregnant aspirin does not increase the risk type 1 or type 2 diabetes are generally re- should be counseled on the risk of devel- of retinal hemorrhage. A peated annually for patients with minimal opment and/or progression of diabetic Diabetic retinopathy is a highly speciﬁc to no retinopathy. In addition, rapid implemen- vascular complication of both type 1 maybecost-effectiveafteroneormore tation of intensive glycemic management and type 2 diabetes, with prevalence normal eye exams, and in a population in the setting of retinopathy is associated stronglyrelatedtoboththeduration with well-controlled type 2 diabetes, there with early worsening of retinopathy (58). Diabetic retinopathy is the most signiﬁcant retinopathy with a 3-year inter- mellitus do not require eye examinations frequent cause of new cases of blind- val after a normal examination (59). More during pregnancy and do not appear to be ness among adults aged 20–74 years in frequent examinations by the ophthal- at increased risk of developing diabetic ret- developed countries. Glaucoma, cata- mologist will be required if retinopathy inopathy during pregnancy (66). High- treatment when vision loss can be pre- with, retinopathy include chronic hypergly- quality fundus photographs can detect vented or reversed. Intensive most clinically signiﬁcant diabetic reti- Photocoagulation Surgery diabetes management with the goal of nopathy. Retinalphotosarenot asubstitute in treated eyes with the greatest beneﬁt ditional beneﬁt (54). Several case series and a Type 1 Diabetes ser photocoagulation is still commonly controlled prospective study suggest that Because retinopathy is estimated to take used to manage complications of diabetic pregnancy in patients with type 1 diabetes at least 5 years to develop after the onset retinopathythat involveretinalneovascu- may aggravate retinopathy and threaten of hyperglycemia, patients with type 1 di- larization and its complications. Symptoms vary agents provide a more effective treat- vent or delay the development of according to the class of sensory ﬁbers ment regimen for central-involved dia- neuropathy in patients with type 1 involved.
10 of 10 - Review by Z. Jack
Votes: 230 votes
Total customer reviews: 230